|
U.S. News FDA Panel Rules Against NeurogesX Patch for HIV-Related NeuropathyFebruary 15, 2012 A Food and Drug Administration panel of outside experts has ruled against using a product derived from chili peppers to treat neuropathic pain in people with HIV. The committee voted 12-0 that clinical data do not show substantial evidence that NeurogesX Inc.'s Qutenza is effective against pain in the extremities suffered by many HIV patients. The experts also voted 11-0, with one abstention, that the capsaicin patch's risk-benefit profile was not acceptable for use by persons with HIV. Back to other news for February 2012 View Full Article Visit the CDC's website to find out more about their activities, publications and services.
Comment by: AsianPrince
(Kuala Lumpur, Malaysia)
Fri., Feb. 17, 2012 at 6:34 am EST @psgoodguy, Would you mind to share with the rest of us, what's this pain all about? Some of us would like to know more
Comment by: psgoodguy
(palm springs, ca)
Thu., Feb. 16, 2012 at 2:26 pm EST i was a volunteer in this study. the pain was excruciating.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|